Caricamento...
Targeting von Willebrand Factor in Ischaemic Stroke: Focus on Clinical Evidence
Despite great efforts in stroke research, disability and recurrence rates in ischaemic stroke remain unacceptably high. To address this issue, one potential target for novel therapeutics is the glycoprotein von Willebrand factor (vWF), which increases in thrombogenicity especially under high shear r...
Salvato in:
| Pubblicato in: | Thromb Haemost |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Schattauer GmbH
2018
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6193403/ https://ncbi.nlm.nih.gov/pubmed/29847840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1648251 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|